InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | Validation of a small molecule inhibitor of PDE6D-RAS interaction with favora... | 2022 | Blood Cancer J. | Canovas Nunes S. et al. | DOI: 10.1038/s41408-022-00663-z |
| Blasticidin | Validation of a small molecule inhibitor of PDE6D-RAS interaction with favora... | 2022 | Blood Cancer J. | Canovas Nunes S. et al. | DOI: 10.1038/s41408-022-00663-z |
| Primocin® | Immunofluorescent visualization of mouse interneuron subtypes. | 2022 | F1000Res | Molgaard S. et al. | DOI: 10.12688/f1000research.5349.2 |
| LPS-EK (LPS from E. coli K12) | Pregnancy tailors endotoxin-induced monocyte and neutrophil responses in the ... | 2022 | Inflamm Res. | Farias-Jofre M. et al. | DOI: 10.1007/s00011-022-01569-z |
| Poly(dA:dT) | The AIM2 inflammasome is activated in astrocytes during the late phase of EAE. | 2022 | JCI Insight | Barclay W.E. et al. | DOI: 10.1172/jci.insight.155563 |
| LPS-EB (LPS from E. coli O111:B4) | The AIM2 inflammasome is activated in astrocytes during the late phase of EAE. | 2022 | JCI Insight | Barclay W.E. et al. | DOI: 10.1172/jci.insight.155563 |
| Tri-DAP | Peptidoglycan from Akkermansia muciniphila Muc T: chemical structure and immu... | 2022 | Glycobiology | Garcia-Vello P. et al. | DOI: 10.1093/glycob/cwac027 |
| PGN-ECndss ultrapure peptidoglycan | Peptidoglycan from Akkermansia muciniphila Muc T: chemical structure and immu... | 2022 | Glycobiology | Garcia-Vello P. et al. | DOI: 10.1093/glycob/cwac027 |
| HEK-Blue™ Detection | Engineering a suite of E. coli strains for enhanced expression of bacterial p... | 2022 | Microb Cell Fact. | Kay E.J. et al. | DOI: 10.1186/s12934-022-01792-7 |
| Human TLR4 Reporter HEK293 Cells (NF-κB) | Engineering a suite of E. coli strains for enhanced expression of bacterial p... | 2022 | Microb Cell Fact. | Kay E.J. et al. | DOI: 10.1186/s12934-022-01792-7 |
| HEK-Blue™ Selection | Engineering a suite of E. coli strains for enhanced expression of bacterial p... | 2022 | Microb Cell Fact. | Kay E.J. et al. | DOI: 10.1186/s12934-022-01792-7 |
| Normocin® - Antimicrobial Reagent | Engineering a suite of E. coli strains for enhanced expression of bacterial p... | 2022 | Microb Cell Fact. | Kay E.J. et al. | DOI: 10.1186/s12934-022-01792-7 |
| Zymosan | Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are ... | 2022 | Front Immunol | Kastelberg B. et al. | DOI: 10.3389/fimmu.2021.749504 |
| Curdlan | Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are ... | 2022 | Front Immunol | Kastelberg B. et al. | DOI: 10.3389/fimmu.2021.749504 |
| Zymosan Depleted | Nlrx1-Regulated Defense and Metabolic Responses to Aspergillus fumigatus Are ... | 2022 | Front Immunol | Kastelberg B. et al. | DOI: 10.3389/fimmu.2021.749504 |
| QUANTI-Blue™ | Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel d... | 2022 | Pharmacol Res. | Mahmoud N. et al. | DOI: 10.1016/j.phrs.2022.106233 |
| Human TLR3 Reporter HEK293 Cells (NF-κB) | Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activ... | 2022 | Cell Mol Immunol. | Kim C.U. et al. | DOI: 10.1038/s41423-022-00862-5 |
| Human TLR5 Reporter HEK293 Cells (NF-κB) | Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activ... | 2022 | Cell Mol Immunol. | Kim C.U. et al. | DOI: 10.1038/s41423-022-00862-5 |
| HEK-Blue™ Detection | Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activ... | 2022 | Cell Mol Immunol. | Kim C.U. et al. | DOI: 10.1038/s41423-022-00862-5 |
| Pam3CSK4 | Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activ... | 2022 | Cell Mol Immunol. | Kim C.U. et al. | DOI: 10.1038/s41423-022-00862-5 |